DE3766839D1 - 5,6-dihydro-2-(substituiertes phenyl)-1,2,4-triazin-3,5(2h,4h)-dione. - Google Patents

5,6-dihydro-2-(substituiertes phenyl)-1,2,4-triazin-3,5(2h,4h)-dione.

Info

Publication number
DE3766839D1
DE3766839D1 DE8787200088T DE3766839T DE3766839D1 DE 3766839 D1 DE3766839 D1 DE 3766839D1 DE 8787200088 T DE8787200088 T DE 8787200088T DE 3766839 T DE3766839 T DE 3766839T DE 3766839 D1 DE3766839 D1 DE 3766839D1
Authority
DE
Germany
Prior art keywords
compounds
triazine
dihydro
substituted phenyl
dione
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787200088T
Other languages
English (en)
Inventor
Gustaaf Maria Boeckx
Alfons Herman Marg Raeymaekers
Victor Sipido
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of DE3766839D1 publication Critical patent/DE3766839D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fodder In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
DE8787200088T 1986-01-30 1987-01-21 5,6-dihydro-2-(substituiertes phenyl)-1,2,4-triazin-3,5(2h,4h)-dione. Expired - Fee Related DE3766839D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868602342A GB8602342D0 (en) 1986-01-30 1986-01-30 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones

Publications (1)

Publication Number Publication Date
DE3766839D1 true DE3766839D1 (de) 1991-02-07

Family

ID=10592258

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787200088T Expired - Fee Related DE3766839D1 (de) 1986-01-30 1987-01-21 5,6-dihydro-2-(substituiertes phenyl)-1,2,4-triazin-3,5(2h,4h)-dione.

Country Status (21)

Country Link
US (3) US4767760A (de)
EP (1) EP0232932B1 (de)
JP (2) JPH0813806B2 (de)
CN (1) CN1017049B (de)
AT (1) ATE59644T1 (de)
AU (1) AU586731B2 (de)
CA (2) CA1288772C (de)
DE (1) DE3766839D1 (de)
DK (2) DK169032B1 (de)
ES (1) ES2031876T3 (de)
FI (1) FI94634C (de)
GB (1) GB8602342D0 (de)
GR (1) GR3001392T3 (de)
IE (1) IE59510B1 (de)
IL (1) IL81421A (de)
NO (1) NO172690C (de)
NZ (1) NZ218973A (de)
PT (1) PT84218B (de)
RU (1) RU2017736C1 (de)
SU (1) SU1595339A3 (de)
ZA (1) ZA87672B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097779A (en) * 1976-04-05 1978-06-27 Gte Sylvania Incorporated Fluorescent lamp containing a cathode heater circuit disconnect device
US4156831A (en) * 1978-05-24 1979-05-29 Gte Sylvania Incorporated Fluorescent lamp having heater circuit disconnect device
GB8602342D0 (en) * 1986-01-30 1986-03-05 Janssen Pharmaceutica Nv 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones
DE3826058A1 (de) * 1988-07-30 1990-02-08 Bayer Ag Mittel gegen fischparasiten
US5070091A (en) * 1989-01-09 1991-12-03 Bayer Aktiengesellschaft Substituted 1,2,4-triazinediones useful against protozoa in insects
EP0377903A3 (de) * 1989-01-09 1991-07-17 Bayer Ag Substituierte Hexahydro-1,2,4-triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
CN1044905A (zh) * 1989-02-16 1990-08-29 赫彻斯特股份公司 鱼和昆虫寄生虫对抗剂
CA2012004A1 (en) * 1989-03-15 1990-09-15 Frank Ellis Chemical compounds
EP0476439A1 (de) * 1990-09-18 1992-03-25 Bayer Ag Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
DE4120138A1 (de) * 1991-06-19 1992-12-24 Bayer Ag Substituierte hexahydro-1,2,4-triazindione, verfahren zu ihrer herstellung, zwischenprodukte dafuer und ihre verwendung
US5994355A (en) * 1993-10-15 1999-11-30 Takeda Chemical Industries, Ltd. 1, 2, 4-Triazin-3-one derivatives, production and use thereof
EP0737672B1 (de) * 1995-04-14 2001-10-04 Takeda Schering-Plough Animal Health K.K. Verfahren zur Herstellung von Triazinderivate
US5747476A (en) * 1996-07-17 1998-05-05 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoal myeloencephalitis
EP0831088B1 (de) * 1996-08-30 2002-11-27 Takeda Schering-Plough Animal Health K.K. 1,2,4-Triazin-3,5-Dionderivate als Anticoccidiosemittel
WO1998043644A1 (en) * 1997-03-31 1998-10-08 David Granstrom Formulations and methods to treat and prevent equine protozoal myeloencephalitis
US5883095A (en) * 1997-08-07 1999-03-16 University Of Kentucky Research Foundation Formulations and methods to treat and prevent equine protozoal myeloencephalitis
US5830893A (en) * 1997-04-23 1998-11-03 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoan myeloencephalitis using triazinediones
CA2294145A1 (en) * 1997-07-10 1999-01-21 Janssen Pharmaceutica N.V. Il-5 inhibiting 6-azauracil derivatives
US6867207B2 (en) 1997-07-10 2005-03-15 Janssen Pharmaceutica N.V. IL-5 inhibiting 6-azauracil derivatives
ID24224A (id) 1997-07-10 2000-07-13 Janssen Pharmaceutica Nv Turunan-turunan 6-azaurasil sebagai inhibitor il-5
US6294536B1 (en) 1997-08-29 2001-09-25 Takeda Schering-Plough Animal Health K.K. Triazine derivatives, their production and use
WO2000006172A1 (en) * 1998-07-27 2000-02-10 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoan myeloencephalitis using triazinediones
EP0987265A1 (de) 1998-09-18 2000-03-22 Janssen Pharmaceutica N.V. Interleukin-5 hemmende 6-Azauracil Derivate
BR9914385A (pt) * 1998-10-08 2001-07-17 New Ace Res Company Composição útil para o tratamento e prevenção de infecções protozoárias no homem e em animais, e, método de tratamento de uma infecção protozoária no homem e em animais
WO2000037451A1 (en) * 1998-12-18 2000-06-29 Janssen Pharmaceutica N.V. Il-5 inhibiting 6-azauracil derivatives
HUP0202692A3 (en) 1999-08-06 2003-01-28 Janssen Pharmaceutica Nv Interleukin-5 inhibiting 6-azauracil derivatives, pharmaceutical compositions containing them and intermediates
PA8591801A1 (es) * 2002-12-31 2004-07-26 Pfizer Prod Inc Inhibidores benzamidicos del receptor p2x7.
GB0622472D0 (en) * 2006-11-10 2006-12-20 Addex Pharmaceuticals Sa Novel heterocyclic derivatives
CN107746390B (zh) * 2017-11-21 2021-03-16 连云港市亚晖医药化工有限公司 抗球虫药地克珠利的制备方法
CN113999139A (zh) * 2021-12-03 2022-02-01 杭州臻峰科技有限公司 制备2，6-二氯-α-（4-氯代苯基） -4-硝基苯乙腈的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3905971A (en) * 1971-03-29 1975-09-16 Pfizer 2-Phenyl-as-triazine-3,5(2H,4H)diones
US3912723A (en) * 1971-03-29 1975-10-14 Pfizer 2-Phenyl-as-triazine-3,5(2H,4H)diones
GB1448696A (en) * 1973-05-29 1976-09-08 Pfizer 2-phqnyl-astriazine-3,4-2h,4h-diones
DE3408924A1 (de) * 1984-03-12 1985-09-26 Hoechst Ag, 6230 Frankfurt Substituierte 2-phenyl-hexahydro-1,2,4-triazin-3,5-dione, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
US4631278A (en) * 1984-08-01 1986-12-23 Janssen Pharmaceutica N.V. Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor
CA1244024A (en) * 1984-08-01 1988-11-01 Gustaaf M. Boeckx .alpha.- ARYL-4-(4,5-DIHYDRO-3,5-DIOXO-1,2,4-TRIAZIN- 2(3H)-YL)BENZENEACETONITRILES
GB8602342D0 (en) * 1986-01-30 1986-03-05 Janssen Pharmaceutica Nv 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones

Also Published As

Publication number Publication date
FI94634C (fi) 1995-10-10
US4912106A (en) 1990-03-27
IE59510B1 (en) 1994-03-09
JPH0813806B2 (ja) 1996-02-14
US4767760A (en) 1988-08-30
AU586731B2 (en) 1989-07-20
IE870231L (en) 1987-07-30
CA1288772C (en) 1991-09-10
GR3001392T3 (en) 1992-09-11
NO870378D0 (no) 1987-01-29
CN87100531A (zh) 1987-09-02
DK169032B1 (da) 1994-08-01
DK48187A (da) 1987-07-31
NO172690B (no) 1993-05-18
GB8602342D0 (en) 1986-03-05
US4952570A (en) 1990-08-28
FI870421A0 (fi) 1987-01-30
CN1017049B (zh) 1992-06-17
DK65193A (da) 1993-06-04
DK48187D0 (da) 1987-01-29
JPS62190174A (ja) 1987-08-20
SU1595339A3 (ru) 1990-09-23
PT84218A (en) 1987-02-01
CA1302411C (en) 1992-06-02
ES2031876T3 (es) 1993-01-01
PT84218B (pt) 1989-07-31
ATE59644T1 (de) 1991-01-15
EP0232932B1 (de) 1991-01-02
IL81421A0 (en) 1987-08-31
JPH07285949A (ja) 1995-10-31
IL81421A (en) 1991-11-21
JP2622510B2 (ja) 1997-06-18
NO870378L (no) 1987-07-31
NZ218973A (en) 1988-10-28
FI870421A (fi) 1987-07-31
EP0232932A1 (de) 1987-08-19
FI94634B (fi) 1995-06-30
RU2017736C1 (ru) 1994-08-15
ZA87672B (en) 1988-09-28
AU6813487A (en) 1987-08-06
DK65193D0 (da) 1993-06-04
NO172690C (no) 1993-08-25

Similar Documents

Publication Publication Date Title
DE3766839D1 (de) 5,6-dihydro-2-(substituiertes phenyl)-1,2,4-triazin-3,5(2h,4h)-dione.
DK0378255T3 (da) 2-aminopyrimidinoderivater
DK74691A (da) 4(4-(substitueret phenyl)-1-piperazinyl)phenoler og fremgangsmaade til fremstilling deraf
EA200000614A1 (ru) 2,3-замещенные соединения индола в качестве ингибиторов сох-2
KR960009422B1 (en) 4-(ardylamino)piperidinebutanamide derivatives
ATE124410T1 (de) Antihypertensive 3-piperidinylindazol-derivate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee